Prof Bruce Campbell: tenecteplase RCT backs up Aussie stroke guidance

There is no advantage in increasing the dose of tenecteplase beyond 0.25 mg/kg, the dose most often used for stroke management in Australia and that recommended by local clinical guidelines. In research presented at the recent American Stroke Association’s International Stroke Conference 2020 in Los Angeles and concurrently published in JAMA, 300 ischaemic stroke patients ...

Already a member?

Login to keep reading.

© 2021 the limbic